Nektar Therapeutics NKTR
NASDAQ NKTR
$60.54 +1.30 (+2.19%)
At close: Sep 30, 2026 · 4:00 PM EDT

Nektar Therapeutics (NKTR) Total Non-Current Liabilities (2010 - 2026)

Updated

Nektar Therapeutics' Total Non-Current Liabilities was $184.21 million in Q2 2026, down 18.5% from $226.11 million a year earlier but up 3.1% from the prior quarter.

Analysis

Nektar Therapeutics (NKTR) Total Non-Current Liabilities (2010 - 2026) Analysis & Trends

At the end of FY2025, Total Non-Current Liabilities at Nektar Therapeutics came in at $181.95 million, down 22.9% from FY2024.

  • Total Non-Current Liabilities has now declined for six consecutive years, with a five-year compound annual growth rate of -16.7% (FY2020 to FY2025).
  • In earlier years, Total Non-Current Liabilities was $235.87 million in FY2024 (-10.1%), $262.41 million in FY2023 (-22.0%), $336.41 million in FY2022 (-17.9%) and $409.96 million in FY2021 (-9.4%).
  • Quarterly Total Non-Current Liabilities has moved between $178.61 million (Q1 2026) and $454.32 million (Q3 2021) over five years.
  • Compared with a year earlier, Total Non-Current Liabilities has declined for 19 straight quarters, with an average decline of 15.5% over the last eight quarters.
  • The best year-over-year quarter for Total Non-Current Liabilities over five years was Q3 2021 (growth of 35.9%); the worst was Q2 2023 (a decline of 27.2%).
  • Per Business Quant data, NKTR's Total Non-Current Liabilities in the three quarters before Q2 2026 was $178.61 million (Q1 2026), $181.95 million (Q4 2025) and $211.24 million (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Total Non-Current Liabilities (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn 105.99 Bn
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn 106.45 Bn
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn 80.25 Bn
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn 48.34 Bn
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn -967.00 Mn
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn 81.11 Bn
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn 36.04 Bn
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn 100.86 Bn
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn 5.92 Bn
10 Nektar Therapeutics 2.00 Bn 232.24 Mn - 184.21 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 184.21 Mn
Mar 31, 2026 178.61 Mn
Dec 31, 2025 181.95 Mn
Sep 30, 2025 211.24 Mn
Jun 30, 2025 226.11 Mn
Mar 31, 2025 235.75 Mn
Dec 31, 2024 235.87 Mn
Sep 30, 2024 252.17 Mn
Jun 30, 2024 255.60 Mn
Mar 31, 2024 264.97 Mn
Dec 31, 2023 262.41 Mn
Sep 30, 2023 277.92 Mn
Jun 30, 2023 292.17 Mn
Mar 31, 2023 314.40 Mn
Dec 31, 2022 336.41 Mn
Sep 30, 2022 365.73 Mn
Jun 30, 2022 401.18 Mn
Mar 31, 2022 416.23 Mn
Dec 31, 2021 409.96 Mn
Sep 30, 2021 454.32 Mn
API Access

Nektar Therapeutics Total Non-Current Liabilities API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=total-non-current-liabilities&ticker=NKTR&period=max&api_key=YOUR_API_KEY